Mylan Inc. has divested its entire 5.64% stake in Biocon through open market transactions worth Rs 3,678.68 crore. Mylan Inc. has sold around 9.20 crore shares of the company at an average price of Rs 400 apiece.
Meanwhile, ICICI Prudential Mutual Fund has bought around 3.69 crore shares worth Rs 1,475 crore at the same price.
Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.
